ubretid
Small moleculeexperimental
Clinical trial activity
0 trials · 0 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Mechanism of action
- AcetylcholinesteraseINHIBITOR
Acetylcholinesterase inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
CN(CCCCCCN(C)C(=O)Oc1ccc[n+](C)c1)C(=O)Oc1ccc[n+](C)c1- Mol. weight
- 416.52 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL1199307 ↗
- ChEMBLCHEMBL1098285 ↗
Also known as
- aventis pharma brand of distigmine
- christiaens brand of distigmine
- distigmine
- distigmine
- distigmine
- distigmine
- distigmine
- distigmine
- distigmine bromide
- distigmine bromide
- distigmine bromide
- distigmine bromide
- hexamarium
- hexamarium
- hexamarium
- hexamarium
- hexamarium
- hexamarium bromide
- hexamarium bromide
- nycomed brand of distigmine
- pyridinium, 3,3'-(1,6-hexanediylbis((methylimino)carbonyl)oxy)bis-1-methyl-, dibromide
- rhône-poulenc rorer brand of distigmine
- ubretid
- ubretid
- ubretid
- ubretid